scispace - formally typeset
M

Michael A. Palladino

Researcher at Nereus Pharmaceuticals

Publications -  177
Citations -  19198

Michael A. Palladino is an academic researcher from Nereus Pharmaceuticals. The author has contributed to research in topics: Proteasome inhibitor & Bortezomib. The author has an hindex of 57, co-authored 176 publications receiving 18857 citations. Previous affiliations of Michael A. Palladino include Genentech & Memorial Sloan Kettering Cancer Center.

Papers
More filters
Journal ArticleDOI

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

TL;DR: Recombinant tumour necrosis factor can be obtained by expression of its complementary DNA in Escherichia coli and induces the haemorrhagic necrosis of transplanted methylcholanthrene-induced sarcomas in syngeneic mice.
Journal ArticleDOI

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro

TL;DR: The observations indicate that the effects of rTNF-alpha on cell growth are not limited to tumor cells, but rather that this protein may have a broad spectrum of activities in vivo.
Journal ArticleDOI

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

TL;DR: These studies show that TNF (cachectin) is another endogenous pyrogen which, like IL-1 and IFN-alpha, directly stimulate hypothalamic PGE2 synthesis and is an endogenous inducer ofIL-1.
Journal ArticleDOI

The two different receptors for tumor necrosis factor mediate distinct cellular responses.

TL;DR: Investigation of the individual roles of the murine type 1 and type 2 tumor necrosis factor (TNF) receptors suggest that TNF-R2 initiates signals for the proliferation of thymocytes and cytotoxicity and the induction of the protective activity, manganous superoxide dismutase.
Journal Article

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

TL;DR: Although lipopolysaccharide (LPS) is a potent stimulator of PMN function, polymyxin B can block LPS-induced but not lymphokine-induced activation, demonstrating new activities for both TNF-alpha and T NF-beta in augmenting the phagocytic and cytotoxic activities of PMn.